Related Experiment Video
Updated: Aug 19, 2025

Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study
Published on: March 31, 2022
Transcriptomic Mapping of Neurotoxicity Pathways in the Rat Brain in Response to Intraventricular Polymyxin B
Jing Lu1,2, Yan Zhu2, Helena C Parkington3
1Department of Pharmacology & Biochemistry, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC, 3010, Australia.
Abstract:
Intraventricular or intrathecal administration of polymyxins are increasingly used to treat multidrug-resistant (MDR) Gram-negative bacteria caused infections in the central nervous system (CNS). However, our limited knowledge of the mechanisms underpinning polymyxin-induced neurotoxicity significantly hinders the development of safe and efficacious polymyxin dosing regimens. To this end, we conducted transcriptomic analyses of the rat brain and spinal cord 1 h following intracerebroventricular administration of polymyxin B into rat lateral ventricle at a clinically relevant dose (0.5 mg/kg). Following the treatment, 66 differentially expressed genes (DEGs) were identified in the brain transcriptome while none for the spinal cord (FDR ≤ 0.05, fold-change ≥ 1.5). DEGs were enriched in signaling pathways associated with hormones and neurotransmitters, including dopamine and (nor)epinephrine. Notably, the expression levels of Slc6a3 and Gabra6 were decreased by 20-fold and 4.3-fold, respectively, likely resulting in major perturbations of dopamine and γ-aminobutyric acid signaling in the brain. Mass spectrometry imaging of brain sections revealed a distinct pattern of polymyxin B distribution with the majority accumulating in the injection-side lateral ventricle and subsequently into third and fourth ventricles. Polymyxin B was not detectable in the left lateral ventricle or brain tissue. Electrophysiological measurements on primary cultured rat neurons revealed a large inward current and significant membrane leakage following polymyxin B treatment. Our work demonstrates, for the first time, the key CNS signaling pathways associated with polymyxin neurotoxicity. This mechanistic insight combined with pharmacokinetic/pharmacodynamic dosing strategies will help guide the design of safe and effective intraventricular/intrathecal polymyxin treatment regimens for CNS infections caused by MDR Gram-negative pathogens.
Insights
Polymyxin B administration into the brain affects dopamine and GABA signaling pathways, potentially causing neurotoxicity. This study identifies key CNS pathways involved in polymyxin neurotoxicity for safer drug regimens.
Area of Science:
- Neuroscience
- Pharmacology
- Infectious Diseases
Background:
- Intraventricular or intrathecal polymyxins treat central nervous system (CNS) infections from multidrug-resistant (MDR) Gram-negative bacteria.
- Limited understanding of polymyxin neurotoxicity mechanisms impedes safe dosing strategies.
Purpose of the Study:
- To investigate the molecular mechanisms of polymyxin B-induced neurotoxicity in the rat CNS.
- To identify key signaling pathways affected by polymyxin B administration.
Main Methods:
- Transcriptomic analysis of rat brain and spinal cord after intracerebroventricular polymyxin B administration.
- Mass spectrometry imaging to determine drug distribution.
- Electrophysiological recordings on cultured rat neurons.
Main Results:
- 66 differentially expressed genes identified in the brain, enriched in dopamine and (nor)epinephrine signaling pathways.
- Significant downregulation of Slc6a3 and Gabra6, impacting dopamine and GABA signaling.
- Polymyxin B primarily localized to ventricles, with no detectable levels in brain tissue; induced neuronal inward current and membrane leakage.
Conclusions:
- Identified key CNS signaling pathways associated with polymyxin neurotoxicity.
- Mechanistic insights and pharmacokinetic/pharmacodynamic data can guide development of safer polymyxin regimens for CNS infections.
More Related Videos
15:05Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons
Published on: February 5, 2015
10:15Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction
Published on: September 15, 2014